share_log

万邦医药(301520.SZ):公司控制的合伙企业拟认购私募基金份额

万邦医药 (301520.SZ): The company-controlled partnership enterprise proposes to subscribe for private equity fund shares.

Gelonghui Finance ·  Nov 26 19:03

On November 26, Glonny announced that Hefei Qunxiangqiming Enterprise Management Partnership Enterprise (Limited Partnership) controlled by the company signed the "Shenzhen Songhe Cell and Genetic Industry Private Equity Fund Partnership Enterprise (Limited Partnership) Partnership Agreement" and related documents with Shenzhen Songhe Capital Management Co., Ltd. on November 22, 2024. Qunxiangqiming, as a limited partner, subscribed 10 million yuan to the Shenzhen Songhe Cell and Genetic Industry Private Equity Fund Partnership Enterprise (Limited Partnership) (tentative name, subject to the name approved by the industrial and commercial registration authority, referred to as the "partnership") with a contribution ratio of 0.67%. The partnership's main investment projects include cell and gene therapy, new virus vectors, research and industrialization of new vaccines, genetic technologies, biological breeding research and industrialization, and upstream industries required in these areas.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment